Search research articles
Contact Us
Filters
Showing results (41-50 of 103) with videos related to
Page
of 11
Sort By:
Psychopharmacology
|
July 4, 2019
NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats
Robert Becker, Natalia Gass, Lothar Kußmaul, et al.
Shock (Augusta, Ga.)
|
October 9, 2012
Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C
David Schnell, Stéphane Deruddre, Anatole Harrois, et al.
The European Respiratory Journal
|
November 13, 2012
Clinical assessment for identifying causes of acute respiratory failure in cancer patients
David Schnell, Julien Mayaux, Jérôme Lambert, et al.
Shock (Augusta, Ga.)
|
January 18, 2013
Impact of a recent chemotherapy on the duration and intensity of the norepinephrine support during septic shock
David Schnell, Sébastien Besset, Etienne Lengliné, et al.
Critical Care Medicine
|
April 18, 2013
Renal perfusion assessment by renal Doppler during fluid challenge in sepsis
David Schnell, Laurent Camous, Stéphane Guyomarc'h, et al.
Investigational New Drugs
|
May 30, 2018
Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors
Sandrine Hiret, Nicolas Isambert, Carlos Gomez-Roca, et al.
Critical Care Medicine
|
July 15, 2016
Acetaminophen-Induced Changes in Systemic Blood Pressure in Critically Ill Patients: Results of a Multicenter Cohort Study
Aymeric Cantais, David Schnell, François Vincent, et al.
Plos One
|
March 5, 2013
Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival
Emmanuel Canet, Lara Zafrani, Jerome Lambert, et al.
Leukemia & Lymphoma
|
December 12, 2013
Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?
Emmanuel Canet, Morgane Cheminant, Lara Zafrani, et al.
Cancer Chemotherapy and Pharmacology
|
November 23, 2016
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors
James Spicer, Sheeba Irshad, Joo Ern Ang, et al.
Page
of 11
Search research articles
Search
Showing results (41-50 of 103) with videos related to
Sort By:
Page
of 11
Psychopharmacology
|
July 4, 2019
NMDA receptor antagonists traxoprodil and lanicemine improve hippocampal-prefrontal coupling and reward-related networks in rats
Robert Becker, Natalia Gass, Lothar Kußmaul, et al.
Shock (Augusta, Ga.)
|
October 9, 2012
Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C
David Schnell, Stéphane Deruddre, Anatole Harrois, et al.
The European Respiratory Journal
|
November 13, 2012
Clinical assessment for identifying causes of acute respiratory failure in cancer patients
David Schnell, Julien Mayaux, Jérôme Lambert, et al.
Shock (Augusta, Ga.)
|
January 18, 2013
Impact of a recent chemotherapy on the duration and intensity of the norepinephrine support during septic shock
David Schnell, Sébastien Besset, Etienne Lengliné, et al.
Critical Care Medicine
|
April 18, 2013
Renal perfusion assessment by renal Doppler during fluid challenge in sepsis
David Schnell, Laurent Camous, Stéphane Guyomarc'h, et al.
Investigational New Drugs
|
May 30, 2018
Phase I dose-escalation trial of afatinib, an irreversible ErbB family blocker, in combination with gemcitabine or docetaxel in patients with relapsed or refractory solid tumors
Sandrine Hiret, Nicolas Isambert, Carlos Gomez-Roca, et al.
Critical Care Medicine
|
July 15, 2016
Acetaminophen-Induced Changes in Systemic Blood Pressure in Critically Ill Patients: Results of a Multicenter Cohort Study
Aymeric Cantais, David Schnell, François Vincent, et al.
Plos One
|
March 5, 2013
Acute kidney injury in patients with newly diagnosed high-grade hematological malignancies: impact on remission and survival
Emmanuel Canet, Lara Zafrani, Jerome Lambert, et al.
Leukemia & Lymphoma
|
December 12, 2013
Plasma uric acid response to rasburicase: early marker for acute kidney injury in tumor lysis syndrome?
Emmanuel Canet, Morgane Cheminant, Lara Zafrani, et al.
Cancer Chemotherapy and Pharmacology
|
November 23, 2016
A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors
James Spicer, Sheeba Irshad, Joo Ern Ang, et al.
Page
of 11